Daniel Rivalti, Ph.D., focuses his practice on patent drafting, prosecution, and strategic counseling, primarily in the chemical, biotechnology, and pharmaceutical areas.
As a registered patent agent, Daniel has extensive experience in handling a wide variety of patent matters before the U.S. Patent and Trademark Office (USPTO) and in several foreign jurisdictions, including drafting and prosecuting patent applications, reissue, and post-grant proceedings; performing patentability, invalidity, and freedom-to-operate analyses; advising clients on prosecution strategies; drafting and filing provisional, utility, design, and Patent Cooperation Treaty applications; responding to office actions; and conducing examiner interviews.
Daniel has handled matters involving a wide range of technologies, many having complex issues concerning solid state forms (polymorphs), including pharmaceuticals, small molecule chemistry, agrochemicals, food science, polymers, and drug delivery systems.
Daniel has extensive research experience. He completed his graduate research at McGill University, after which he completed a post-doctoral fellowship at Florida State University and Virginia Commonwealth University on a research grant from the Bill & Melinda Gates Foundation. He also served as a research assistant professor in the Chemical Development department at Boehringer-Ingelheim. His work has been published in numerous peer-reviewed scientific journals.
